LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,948,179 | -11.6% | 32,513 | +6.3% | 0.00% | 0.0% |
| Q2 2023 | $2,204,602 | +20.8% | 30,577 | +23.2% | 0.00% | 0.0% |
| Q1 2023 | $1,825,097 | +16.3% | 24,811 | +5.6% | 0.00% | 0.0% |
| Q4 2022 | $1,569,868 | -17.6% | 23,501 | +6.2% | 0.00% | 0.0% |
| Q3 2022 | $1,905,000 | -3.7% | 22,120 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $1,979,000 | -24.8% | 22,182 | -5.2% | 0.00% | 0.0% |
| Q1 2022 | $2,632,000 | -25.2% | 23,394 | +2.7% | 0.00% | 0.0% |
| Q4 2021 | $3,519,000 | +0.5% | 22,784 | -9.4% | 0.00% | 0.0% |
| Q3 2021 | $3,502,000 | +9.4% | 25,143 | +3.1% | 0.00% | 0.0% |
| Q2 2021 | $3,200,000 | -21.2% | 24,392 | -8.4% | 0.00% | 0.0% |
| Q1 2021 | $4,059,000 | -19.0% | 26,628 | -47.1% | 0.00% | 0.0% |
| Q4 2020 | $5,011,000 | +28.2% | 50,383 | +22.9% | 0.00% | 0.0% |
| Q3 2020 | $3,908,000 | -26.8% | 40,994 | -14.1% | 0.00% | -50.0% |
| Q2 2020 | $5,336,000 | +4.2% | 47,714 | -32.2% | 0.00% | 0.0% |
| Q1 2020 | $5,120,000 | +0.5% | 70,418 | +44.2% | 0.00% | 0.0% |
| Q4 2019 | $5,093,000 | +85.3% | 48,832 | +76.8% | 0.00% | +100.0% |
| Q3 2019 | $2,749,000 | -47.1% | 27,620 | -39.4% | 0.00% | -60.0% |
| Q2 2019 | $5,199,000 | +17.2% | 45,542 | +29.0% | 0.01% | +25.0% |
| Q1 2019 | $4,437,000 | -17.6% | 35,294 | -11.1% | 0.00% | -33.3% |
| Q4 2018 | $5,387,000 | -43.5% | 39,691 | +14.2% | 0.01% | -33.3% |
| Q3 2018 | $9,538,000 | +20.9% | 34,749 | -8.8% | 0.01% | +12.5% |
| Q2 2018 | $7,889,000 | +31.2% | 38,083 | +4.6% | 0.01% | +33.3% |
| Q1 2018 | $6,013,000 | +17.8% | 36,400 | -2.3% | 0.01% | +20.0% |
| Q4 2017 | $5,104,000 | -20.1% | 37,270 | -20.5% | 0.01% | -16.7% |
| Q3 2017 | $6,387,000 | -51.2% | 46,908 | -56.4% | 0.01% | -53.8% |
| Q2 2017 | $13,075,000 | -2.7% | 107,710 | -15.2% | 0.01% | +8.3% |
| Q1 2017 | $13,444,000 | +39.9% | 127,030 | +34.3% | 0.01% | +20.0% |
| Q4 2016 | $9,613,000 | +25.7% | 94,617 | +26.3% | 0.01% | +42.9% |
| Q3 2016 | $7,649,000 | -24.6% | 74,931 | -11.9% | 0.01% | -36.4% |
| Q2 2016 | $10,139,000 | -0.6% | 85,004 | -10.7% | 0.01% | -8.3% |
| Q1 2016 | $10,196,000 | +11.5% | 95,212 | +12.9% | 0.01% | +20.0% |
| Q4 2015 | $9,141,000 | -2.7% | 84,315 | -23.1% | 0.01% | -9.1% |
| Q3 2015 | $9,393,000 | -31.3% | 109,666 | -19.1% | 0.01% | -15.4% |
| Q2 2015 | $13,675,000 | +92.9% | 135,538 | +47.4% | 0.01% | +85.7% |
| Q1 2015 | $7,090,000 | +51.1% | 91,948 | +4.3% | 0.01% | +75.0% |
| Q4 2014 | $4,693,000 | +8.6% | 88,191 | -4.1% | 0.00% | 0.0% |
| Q3 2014 | $4,322,000 | -44.7% | 91,964 | -26.7% | 0.00% | -33.3% |
| Q2 2014 | $7,815,000 | +16.2% | 125,457 | +25.5% | 0.01% | -14.3% |
| Q1 2014 | $6,724,000 | +21.5% | 99,958 | -5.0% | 0.01% | +40.0% |
| Q4 2013 | $5,534,000 | +130.3% | 105,199 | +89.5% | 0.01% | +150.0% |
| Q3 2013 | $2,403,000 | +85.4% | 55,525 | +60.1% | 0.00% | +100.0% |
| Q2 2013 | $1,296,000 | +69.4% | 34,672 | +20.8% | 0.00% | 0.0% |
| Q1 2013 | $765,000 | – | 28,698 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |